Port Capital LLC Amgen Inc Transaction History

Port Capital LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $207,096 - $233,442	-1,145 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $356 - $416	2 Added 0.17%	1,145 $223,000
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $211,786 - $238,761	1,143 New	1,143 $237,000

2,933

401M

6.59M

6.6M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Port Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Port Capital LLC with notifications on news.